Medrobotics launches Flex Robotic system in US to access and visualise oropharynx, hypopharynx and larynx
The FDA cleared the Flex Robotic System from Medrobotics in July 2015. Now the company has raised $25 million to launch the system for sale to US hospitals. With its flexible scope, it is intended to provide an alternative to traditional line-of-sight approaches used to access and visualise the oropharynx, hypopharynx and larynx.
The system is the first robot-assisted surgical platform with a flexible scope that has been cleared by the FDA for use during transoral procedures.
Comment: On 18 March 2014 Medrobotics received the CE mark for the Flex System and is launching the product in select European markets.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
2 mins